# STEP 1 Drug Database - Pedagogical Mind Map Structure

## 🎯 **LEARNING PHILOSOPHY**
**Order = Understanding**. Each section builds logically from basic mechanisms to complex applications, following how concepts should be learned rather than alphabetical organization.

---

## 🧬 **AUTONOMIC NERVOUS SYSTEM** *(Foundation - Learn First)*
> **Why First**: Underlies cardiovascular, respiratory, and GI pharmacology

### **A. Cholinergic System**
```
Parasympathomimetics (Cholinomimetics)
├── Direct Agonists → Bethanechol, Pilocarpine
└── Indirect Agonists (AChE Inhibitors) → Neostigmine, Physostigmine, Pyridostigmine

Parasympatholytics (Antimuscarinics)  
├── Muscarinic Antagonists → Atropine, Scopolamine, Ipratropium, Oxybutynin
└── Nicotinic Antagonists → Mecamylamine, Succinylcholine, Rocuronium
```

### **B. Adrenergic System**
```
Sympathomimetics
├── Direct Agonists
│   ├── Mixed α/β → Epinephrine  
│   ├── α1/β1 → Norepinephrine
│   ├── α1 → Phenylephrine
│   ├── β1/β2 → Isoproterenol  
│   ├── β1 → Dobutamine
│   └── β2 → Albuterol, Salmeterol
├── Indirect Agonists → Amphetamine, Tyramine
└── Mixed → Ephedrine

Sympatholytics
├── α-Blockers → Prazosin, Doxazosin, Phentolamine
├── β-Blockers → (see cardiovascular section)
└── Central α2-Agonists → Clonidine, Methyldopa
```

---

## 🫀 **CARDIOVASCULAR SYSTEM** *(Build on Autonomic Foundation)*

### **A. RAAS System** *(The Central Cascade)*
```
The Pathway: Renin → Angiotensin I → ACE → Angiotensin II → Effects

1. ACE Inhibitors (-prils) [Block Conversion]
   ├── Captopril → First, contains sulfhydryl group
   ├── Enalapril → Prodrug, proven mortality benefit  
   ├── Lisinopril → No prodrug, long-acting
   └── Ramipril → Stroke prevention

2. ARBs (-sartans) [Block AT1 Receptor]
   ├── Losartan → First ARB
   ├── Valsartan → Heart failure proven
   ├── Irbesartan → Renal protection
   └── Olmesartan → GI side effects

3. Direct Renin Inhibitors → Aliskiren
```

### **B. Adrenergic System** *(Links to Autonomic)*
```
β-Blockers [Vaughan-Williams Class II]
├── Non-selective → Propranolol (crosses BBB, anxiety/tremor)
├── β1-Selective → Metoprolol, Atenolol, Bisoprolol  
└── Mixed α/β → Carvedilol (heart failure proven)

α-Blockers [From Sympatholytics]
└── See autonomic section (Prazosin, Doxazosin)
```

### **C. Calcium System**
```
Calcium Channel Blockers [Vaughan-Williams Class IV]
├── Dihydropyridines (Vascular) [-dipines]
│   ├── Nifedipine → Short-acting, can cause hypotension
│   └── Amlodipine → Long-acting, preferred
└── Non-Dihydropyridines (Cardiac)
    ├── Verapamil → Most cardiac effects, constipation
    └── Diltiazem → Intermediate selectivity
```

### **D. Diuretics** *(By Nephron Site)*
```
Loop Diuretics [Thick Ascending Limb]
└── Furosemide → Most potent, ototoxicity

Thiazide Diuretics [Distal Tubule]  
└── Hydrochlorothiazide → First-line HTN, metabolic effects

K+-Sparing [Collecting Duct]
├── Aldosterone Antagonist → Spironolactone (gynecomastia)
└── ENaC Blockers → Amiloride, Triamterene
```

### **E. Antiarrhythmics** *(Vaughan-Williams Classification)*
```
Class I: Na+ Channel Blockers
├── Ia → Quinidine (blocks Na+ and K+, ↑QT)
├── Ib → Lidocaine (shortens AP, damaged tissue)  
└── Ic → Flecainide (slows conduction, avoid in CAD)

Class II: β-Blockers → See adrenergic section

Class III: K+ Channel Blockers  
└── Amiodarone (pulmonary/thyroid toxicity)

Class IV: Ca2+ Channel Blockers → See calcium system

Miscellaneous
└── Digoxin (Na+/K+-ATPase, narrow therapeutic index)
```

### **F. Lipid Management**
```
Statins (-statins) [HMG-CoA Reductase Inhibitors]
├── Atorvastatin → Most common
├── Simvastatin → More interactions
├── Rosuvastatin → Most potent
└── Pravastatin → Hydrophilic, pregnancy-safe
```

### **G. Anticoagulation/Antiplatelet**
```
Anticoagulants
├── Warfarin → Vitamin K antagonist, narrow window
└── Heparin → Antithrombin III, monitor aPTT

Antiplatelets  
├── Aspirin → Irreversible COX inhibition
└── Clopidogrel → P2Y12 inhibitor, prodrug
```

### **H. Vasodilators**
```
Nitrates [Venodilation, Preload ↓]
├── Nitroglycerin → Acute, sublingual
└── Isosorbide mononitrate → Chronic, asymmetric dosing

Direct Vasodilators
└── Hydralazine → Arterial, lupus-like syndrome
```

---

## 🌬️ **RESPIRATORY SYSTEM** *(Uses Autonomic + Some Unique)*

### **A. Bronchodilators** *(From Autonomic System)*
```
Sympathomimetics [β2-Agonists]
├── Short-Acting (SABA) → Albuterol (rescue)
└── Long-Acting (LABA) → Salmeterol (maintenance, + ICS)

Parasympatholytics [Muscarinic Antagonists]  
├── Short-Acting (SAMA) → Ipratropium (COPD first-line)
└── Long-Acting (LAMA) → Tiotropium (once daily)
```

### **B. Anti-Inflammatory**
```
Corticosteroids
├── Inhaled (ICS) → Beclomethasone (rinse mouth)
└── Systemic → Prednisone (multiple effects)

Leukotriene Modifiers
└── Montelukast (oral, psychiatric effects)

Methylxanthines  
└── Theophylline (narrow therapeutic index)
```

---

## 🧠 **NERVOUS SYSTEM** *(Neurotransmitter-Based)*

### **A. GABA System** *(Inhibitory)*
```
GABA Enhancers
├── Benzodiazepines → Lorazepam, Diazepam (anxiolytic, anticonvulsant)
├── Barbiturates → (older, more dangerous)
└── Z-drugs → Zolpidem (sleep-selective)

GABA in Epilepsy → Valproic acid (broad spectrum)
```

### **B. Glutamate System** *(Excitatory)*
```
Glutamate Antagonists
├── NMDA Antagonists → Ketamine (anesthetic)
└── AMPA Antagonists → (seizure research)
```

### **C. Sodium Channel System** *(Neuronal Excitability)*
```
Na+ Channel Blockers
├── Antiepileptics → Phenytoin, Carbamazepine, Lamotrigine
└── Local Anesthetics → Lidocaine (also Class Ib antiarrhythmic)
```

### **D. Dopamine System**
```
Parkinson's Disease [Dopamine ↑]
├── Dopamine Precursor → Levodopa/Carbidopa
├── Dopamine Agonists → Pramipexole, Ropinirole
└── MAO-B Inhibitors → Selegiline

Psychosis [Dopamine ↓]  
├── Typical Antipsychotics → Haloperidol (high EPS)
└── Atypical Antipsychotics → Risperidone (lower EPS)
```

### **E. Serotonin System**
```
Depression [Serotonin ↑]
├── SSRIs → Fluoxetine, Sertraline, Paroxetine, Citalopram
├── SNRIs → Venlafaxine, Duloxetine  
├── Atypical → Bupropion (DA/NE, no sexual effects)
└── TCAs → Amitriptyline (anticholinergic)

Migraine → Sumatriptan (5-HT1B/1D agonist)
Nausea → Ondansetron (5-HT3 antagonist)
```

### **F. Mood Stabilizers**
```
Bipolar Disorder
├── Lithium → Narrow therapeutic index, renal/thyroid
├── Valproic acid → Also antiepileptic
└── Lamotrigine → Also antiepileptic, rash risk
```

---

## 🦠 **ANTIMICROBIALS** *(Target-Based)*

### **A. Cell Wall Synthesis Inhibitors**
```
β-Lactams [PBP Binding]
├── Penicillins
│   ├── Natural → Penicillin G (narrow spectrum)
│   └── Aminopenicillins → Amoxicillin (broader)
├── Cephalosporins [Generation = Spectrum]
│   ├── 1st Gen → Cephalexin (gram +)
│   ├── 2nd Gen → Cefuroxime  
│   ├── 3rd Gen → Ceftriaxone (CNS penetration)
│   └── 4th Gen → Cefepime (Pseudomonas)
└── Glycopeptides → Vancomycin (MRSA, red man syndrome)
```

### **B. Protein Synthesis Inhibitors**
```
30S Ribosome
├── Aminoglycosides → Gentamicin (nephro/ototoxic)
└── Tetracyclines → Doxycycline (photosensitivity)

50S Ribosome  
├── Macrolides → Azithromycin (QT prolongation)
└── Lincosamides → Clindamycin (C. diff risk)
```

### **C. DNA/RNA Synthesis Inhibitors**
```
DNA Gyrase → Fluoroquinolones (generations 2→4)
├── 2nd Gen → Ciprofloxacin (broad spectrum)
├── 3rd Gen → Levofloxacin (respiratory)
└── 4th Gen → Moxifloxacin (anaerobes)

DNA Damage → Metronidazole (anaerobes, avoid alcohol)
```

### **D. Folate Synthesis Inhibitors**
```
Sequential Blockade
└── TMP-SMX (synergistic, PCP prophylaxis)
```

### **E. Antifungals**
```
Ergosterol Synthesis → Fluconazole (azole, many interactions)
Membrane Disruption → Amphotericin B (nephrotoxic, gold standard)
```

### **F. Antivirals**
```
DNA Polymerase → Acyclovir (HSV/VZV, requires viral TK)
```

---

## 🍽️ **GASTROINTESTINAL SYSTEM**

### **A. Acid Suppression** *(Stepwise Intensity)*
```
Proton Pump Inhibitors → Omeprazole (irreversible, most potent)
H2 Receptor Antagonists → Ranitidine (less potent than PPIs)
Antacids → (immediate, short-acting)
```

### **B. Motility** *(From Autonomic)*
```
Prokinetic → Uses cholinergic system
Antidiarrheal → Loperamide (peripheral opioid agonist)
```

### **C. Nausea/Vomiting** *(Neurotransmitter-Based)*
```
5-HT3 Antagonists → Ondansetron (chemo-induced)
D2 Antagonists → Metoclopramide (prokinetic + antiemetic)
```

---

## 🩸 **ENDOCRINE SYSTEM**

### **A. Diabetes** *(Glucose Homeostasis)*
```
Insulin → Multiple formulations (rapid → long-acting)

Non-Insulin Antidiabetics
├── Metformin → Decreases hepatic glucose production
├── Sulfonylureas → Glipizide, Glyburide (hypoglycemia risk)  
├── TZDs → Pioglitazone (insulin sensitizer, heart failure risk)
├── DPP-4 Inhibitors → Sitagliptin (weight neutral)
└── GLP-1 Agonists → Exenatide (weight loss, pancreatitis)
```

### **B. Thyroid**
```
Hypothyroidism → Levothyroxine (T4 replacement)
Hyperthyroidism → Methimazole (thyroid peroxidase inhibition)
```

### **C. Corticosteroids** *(Crosses Multiple Systems)*
```
Systemic → Prednisone (multiple effects, taper slowly)
Inhaled → Beclomethasone (respiratory)
```

---

## 💊 **ANALGESICS/ANTI-INFLAMMATORY**

### **A. NSAIDs** *(COX Selectivity)*
```
Non-Selective → Aspirin (irreversible), Ibuprofen (reversible)
COX-2 Selective → Celecoxib (lower GI risk, higher CV risk)
```

### **B. Gout**
```
Acute → Colchicine (microtubule inhibitor)
Chronic → Allopurinol (xanthine oxidase inhibitor)
```

---

## 🧬 **ONCOLOGY/IMMUNOLOGY**

### **A. Antimetabolites**
```
Folate Antagonist → Methotrexate (+ folic acid supplementation)
```

### **B. Alkylating Agents**  
```
Cyclophosphamide → Hemorrhagic cystitis (give mesna)
```

---

## 🎯 **LEARNING PATHWAYS & CROSS-REFERENCES**

### **Major Cross-System Connections:**
1. **Autonomic → Cardiovascular** (β-blockers, α-blockers)
2. **Autonomic → Respiratory** (β2-agonists, muscarinic antagonists)  
3. **Sodium Channels** → Cardiac (antiarrhythmics) + Neuro (antiepileptics) + Local anesthetics
4. **Corticosteroids** → Endocrine + Respiratory + Inflammatory
5. **Serotonin** → Depression + Migraine + Nausea
6. **Cholinesterase Inhibitors** → Autonomic + Alzheimer's + Myasthenia Gravis

---

This structure transforms your database from a **reference tool** into a **learning progression** that builds understanding systematically!